|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 东准噶尔盆地巴塔玛依内山组火山岩锆石U-Pb年代及Hf同位素研究显示文摘对准噶尔盆地陆梁隆起东部三参1井所钻巴塔玛依内山组玄武岩,开展了详细锆石内部结构研究基础上的U-Pb年代学、微量元素和Hf同位素系统分析.结果显示,所有锆石都属岩浆成因,都有一致的稀土配分型式,都具明显的Ce正异常(δCe=5.06~134)、Eu负异常(δEu=0.06~0.55)和重稀土元素富集特征.25颗锆石中,谐和年龄主要分成3组,分别是(300.4±1.3)Ma(n=11),(339.2±2.7)Ma(n=3)和(392.0±1.7)Ma(n=8);此外,还有3颗近谐和年龄锆石,它们的206Pb/238U年龄分别是(510±7),(488±6)和(453±6)Ma.最小的谐和年龄为(300.4±1.3)Ma,可以代表巴塔玛依内山组火山岩的形成时代(如晚阶段年龄).其他年龄如早泥盆世、奥陶纪等,与盆地周缘岛弧火山岩(富集Pb)和蛇绿岩的时代一致,而且这些年龄锆石都具有正的εHf(t)值(+3.6^+10.5),推测所研究火山岩穿越的盆地基底,可能与由早古生代-中古生代的残余洋壳和岛弧地体组成有关.晚石炭世锆石的εHf(t)值变化于+17.1^+4.2,显示该玄武岩主要来源于软流圈地幔或亏损岩石圈地幔熔融作用,熔体在上升-侵位过程中混染了少量较古老基底物质组分.由于这些玄武岩是后碰撞幔源岩浆直接加入到地壳的物质表现,推测东准噶尔地区晚石炭世已经有了大规模的陆壳垂向生长过程. | 苏玉平 郑建平 Griffin William L 汤华云 O'Reilly Suzanne Y 林向洋 | 2010 | 科学通报2010，55，30： | 50 |
| 2 | Zircon U-Pb and Hf isotopes of volcanic rocks from the Batamayineishan Formation in the eastern Junggar Basin显示文摘内部结构的研究被进行从 Batamayineishan 形成调查 U-Pb 年龄,踪迹元素和玄武岩的锆石的 Hf 同位素。暗岩从练习井圣罐头被获得 1 在 Junggar 盆以内在东方 Luliang 上高举。跟踪所有样品是 magmatic 的锆石表演的元素数据,与类似的 REE 模式,包括积极 Ce (Ce=5.06134 ) ,而是否定 Eu (Eu=0.06 ? 0.55 ) 在重稀土元素元素的异例和丰富。在 25 谷物之中,一致年龄被细分进三个组;300.4 整潲祺潧整的年龄? | SU YuPing ZHENG JianPing GRIFFIN William L TANG HuaYun O'REILLY Suzanne Y LIN XiangYang | 2010 | Chinese Science Bulletin2010，55，36： | 21 |
| 3 | 古老大陆岩石圈地幔再循环与蛇绿岩中铬铁矿床成因显示文摘不同地区、不同时代蛇绿岩中不同类型铬铁矿岩的Re-Os同位素研究表明,在铬铁矿石或围岩中均存在极度亏损的具有大陆岩石圈地幔属性的物质。新疆达拉布特古生代蛇绿岩带中萨尔托海富Al铬铁矿岩的Os同位素组成为0.1109~0.1256,对应的模式年龄为3.5~0.6Ga;西藏班公湖—怒江中生代蛇绿岩带中东巧富Cr铬铁矿石及围岩Os同位素组成介于0.1175~0.1261,对应的模式年龄为1.5~0.1Ga;雅鲁藏布江中生代蛇绿岩带中罗布莎富Cr铬铁矿岩的Os同位素变化范围为0.1038~0.1266,对应的模式年龄为3.37~0.28Ga,而该带中不含矿的泽当二辉橄榄岩的Os同位素组成为0.1256~0.1261,没有古老大陆岩石圈地幔属性的物质存在,与新特提斯洋地幔Os组成较为接近。推测在蛇绿岩形成过程中,古老大陆岩石圈地幔参与循环有利于形成铬铁矿床,明确提出'熔体与古老大陆岩石圈地幔反应成矿'的假说,指出蛇绿岩带中存在的古老微陆块可能是找矿的指示标志。 | 史仁灯 黄启帅 刘德亮 樊帅权 张晓冉 丁林 William L GRIFFIN Suzanne Y O'REILLY | 2012 | 地质论评2012，58，4： | 15 |
| 4 | Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial显示文摘 | Surya SAY Biere Mark I van Berge Henegouwen Kirsten W Maas Luigi Bonavina Camiel Rosman Josep Roig Garcia Suzanne S Gisbertz Jean HG Klinkenbijl Markus W Hollmann Elly SM de Lange H Jaap Bonjer Donald L van der Peet Miguel A Cuesta | 2012 | The Lancet . 2012 (9829)2012，，： | 3 |
| 5 | Measurement of the intestinal permeability in chronic kidney disease显示文摘AIM: To evaluate methods measuring the intestinal permeability in chronic kidney disease(CKD) and clarify whether there is an increased intestinal permeability in CKD.METHODS: We reviewed the literature in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis(PRISMA) protocol and performed a systematic literature search through MEDline and EMBASE. All controlled trials and cohort studies using non-invasive methods to assess intestinal permeability in CKD patients were included. Excluded were: Conference abstracts and studies including patients younger than 18 years or animals. From the included studies we summarized the used methods and their advantages and disadvantages. For the comparison of their results we divided the included studies in two categories based on their included patient population, either assessing the intestinal permeability in mild to moderate CKD patients or in end stage renal disease(ESRD) patients. Results were graphically displayed in two plots, one comparing the intestinal permeability in mild to moderate CKD patients to healthy controls and one comparing the intestinal permeability in ESRD patients to healthy controls. RESULTS: From the 480 identified reports, 15 met our inclusion criteria. Methods that were used to assess the intestinal permeability varied from markers measured in plasma to methods based on calculating the urinary excretion of an orally administered test substance. None of the applied methods has been validated in CKD patients and the influence of decreased renal function on the different methods remains unclear to a certain extent. Methods that seem the least likely to be influenced by decreased renal function are the quantitative PCR(qPCR) for bacterial DNA in blood and D-lactate. Considering the results published by the included studies; the studies including patients with mild to moderate CKD conducted conflicting results. Some studies did report an increase in intestinal permeability whilst other did not find a significant increased permeability. However, despite the variety in used methods among the different studies, all studies measuring the intestinal permeability in ESRD point out a significant increased intestinal permeability. Results should nevertheless be interpreted with caution due to the possible influence of a decreased glomerular filtration rate on test results.CONCLUSION: The intestinal permeability in CKD:(1) could be measured by qPCR for bacterial DNA in blood and D-lactate; and(2) seems to be increased in ESRD. | Matty L Terpstra Ramandeep Singh Suzanne E Geerlings Frederike J Bemelman | 2016 | World Journal of Nephrology2016，5，4： | 2 |
| 6 | Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity显示文摘 | Suzanne L Topalian Charles G Drake Drew M Pardoll | 2011 | Current Opinion in Immunology2011，，2： | 2 |
| 7 | Association of cardiovascular system medications with cognitive function and dementia in older adults living in nursing homes in Australia显示文摘ObjectiveTo 在在检验生活和资源使用的质量的 17 所澳大利亚的疗养院的代表性的研究的 Australia.MethodsAs 部分住在疗养院的更老的成年人与认知功能和痴呆的诊断检验在心血管的系统药使用之间的协会,我们检验了在认知缺陷和心血管的药使用之间的协会(使用解剖治疗学的分类系统识别)用一般线性回归和逻辑 regressio 正在收到生活照顾的结束的人是包括的 excluded.ResultsParticipants 有一个平均数的 541 个居民 85.5 | Enwu Liu Suzanne M Dyer Lisa Kouladjian O'Donnell Rachel Milte Clare Bradley Stephanie L Harrison Emmanuel Gnanamanickam Craig Whitehead Maria Crotty | 2017 | Journal of Geriatric Cardiology2017，14，6： | 2 |
| 8 | Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses显示文摘 | Suzanne L Tomchucka Kevin J | 2008 | stem cells2008，26，1： | 1 |
| 9 | Microparticles of poly (DL-lactic-co-glycolic acid)/poly (ethylene glycol) blends for controlled drug delivery 显示文摘 | ROBERT L C KAREN C K SUZANNE G E | 1997 | J Control Rel1997，48，： | 1 |
| 10 | Finite element a- nalysis of an involute spline 显示文摘 | ZELLA L KAHN J SUZANNE W | 2002 | Journal of Mechani- cal Design2002，122，2： | 1 |
| 11 | Accuracy of t ransmission CT and FDG PET in the detection of small pulmonary nodules with integrated PET/CT显示文摘 | Suzanne L Aquino I Landon B | | 0，，06： | 1 |
| 12 | Metabolic phenotype of isoflavones differ among female rats,pigs,monkeys,and women显示文摘 | Liwei Gu Suzanne E Ronald L | 2006 | J Nutr2006，136，3： | 1 |
| 13 | Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial显示文摘 | Surya SAY Biere Mark I van Berge Henegouwen Kirsten W Maas Luigi Bonavina Camiel Rosman Josep Roig Garcia Suzanne S Gisbertz Jean HG Klinkenbijl Markus W Hollmann Elly SM de Lange H Jaap Bonjer Donald L van der Peet Miguel A Cuesta | 2012 | The Lancet2012，，9829： | 1 |
| 14 | Cathepsin cysteine proteases in cardiovascular disease 显示文摘 | Suzanne L Kitty C Mat J | 2007 | FASEB J2007，21，12： | 1 |
| 15 | Microparticles of poly ( DL-lactic-co-glycolic acid )/poly ( ethylene glycol ) blends for controlled drug delivery 显示文摘 | Robert L Cleek Karen C Ting Suzanne G Eskin | 1997 | J Controlled Release1997，48，： | 1 |
| 16 | Follow-up study of the GIGYF2gene in French families with Parkinson’s disease显示文摘 | Suzanne L Christel C Ebba L | 2010 | Neurobiology ofAging2010，31，6： | 1 |
| 17 | Wheat regenerated from scutellum callus as a source of material for transforma- tion显示文摘 | Harvey A Moisan L Suzanne L | 1999 | Plant Cell Tissue and Organ Culture1999，57，： | 1 |
| 18 | Grain size dependency in the occurrence of sand waves显示文摘 | Hennie Henri?t Veen Suzanne Jacqueline Marie Hélène Hulscher Michiel Adrianus Frederik Knaapen | 2006 | Ocean Dynamics (-)2006，，3： | 1 |
| 19 | Dimethylsulfoniopropi- onate cleavage by marine phytoplankton in response to mechani- cal,chemical or dark stress显示文摘 | Gordon V W Suzanne L S Jan L H | 2002 | Journal of Phycology2002，38，： | 1 |
| 20 | Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease显示文摘 | Stephen B Hanauer Carrie L Wagner Mohan Bala Lloyd Mayer Suzanne Travers Robert H Diamond Allan Olson Warren Bao Paul Rutgeerts | 2004 | Clinical Gastroenterology and Hepatology2004，，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员